Caricamento...
Targeted therapies for ER+/HER2- metastatic breast cancer
The majority of breast cancers present with estrogen receptor (ER)-positive and human epidermal growth factor receptor (HER2)-negative features and might benefit from endocrine therapy. Although endocrine therapy has notably evolved during the last decades, the invariable appearance of endocrine res...
Salvato in:
| Pubblicato in: | BMC Med |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4462184/ https://ncbi.nlm.nih.gov/pubmed/26059247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-015-0369-5 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|